TherapeuticsMD Inc TXMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TXMD is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $1.87
- Day Range
- $1.86–1.90
- 52-Week Range
- $1.86–4.73
- Bid/Ask
- $1.86 / $1.95
- Market Cap
- $21.45 Mil
- Volume/Avg
- 6,236 / 23,168
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 14.92
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1
- Website
- https://www.therapeuticsmd.com
Valuation
|
Metric
|
TXMD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.73 |
Price/Sales | 14.92 |
Price/Cash Flow | — |
Price/Earnings
TXMD
Financial Strength
|
Metric
|
TXMD
|
|---|---|
Quick Ratio | 1.08 |
Current Ratio | 1.72 |
Interest Coverage | — |
Quick Ratio
TXMD
Profitability
|
Metric
|
TXMD
|
|---|---|
Return on Assets (Normalized) | −10.81% |
Return on Equity (Normalized) | −20.66% |
Return on Invested Capital (Normalized) | −16.28% |
Return on Assets
TXMD
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Psllbrpvrj | Tjnl | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Ywpzwlvmhq | Llplz | $70.8 Bil | |
HLN
| Haleon PLC ADR | Wghffxbx | Jhv | $38.2 Bil | |
VTRS
| Viatris Inc | Jjljqxl | Bxrj | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qkwmbfh | Wrtkt | $12.5 Bil | |
CTLT
| Catalent Inc | Nvyskfpll | Rmzvyh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Xjqfcqm | Zvmg | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Tqxmcvnl | Jmm | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Kbhktrf | Gbxhsk | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Cwbjnrqr | Bltyh | $2.9 Bil |